Literature DB >> 24253660

Therapeutic drug monitoring as a component of personalized medicine: applications in pediatric drug development.

J D Momper1, J A Wagner2.   

Abstract

Therapeutic drug monitoring (TDM) is foundational to the concept of personalized medicine. TDM transformed drug therapy by affording the ability to characterize sources of variability in drug disposition and response to individualize drug dosing. Initially, TDM formed the key conceptual basis for personalized medicine, which has evolved to include pharmacogenomic and other biomarker-driven strategies for patient segmentation. Currently, TDM is an attractive option for personalized medicine and, under the right conditions, can facilitate drug development.

Entities:  

Mesh:

Year:  2013        PMID: 24253660     DOI: 10.1038/clpt.2013.227

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  6 in total

1.  A Multiagent System for Dynamic Data Aggregation in Medical Research.

Authors:  Alevtina Dubovitskaya; Visara Urovi; Imanol Barba; Karl Aberer; Michael Ignaz Schumacher
Journal:  Biomed Res Int       Date:  2016-11-16       Impact factor: 3.411

Review 2.  Innovative Study Designs Optimizing Clinical Pharmacology Research in Infants and Children.

Authors:  Stephen J Balevic; Michael Cohen-Wolkowiez
Journal:  J Clin Pharmacol       Date:  2018-10       Impact factor: 2.860

Review 3.  On the Slow Diffusion of Point-of-Care Systems in Therapeutic Drug Monitoring.

Authors:  Barbara Sanavio; Silke Krol
Journal:  Front Bioeng Biotechnol       Date:  2015-02-26

4.  Development of a Pediatric Physiologically Based Pharmacokinetic Model for Sirolimus: Applying Principles of Growth and Maturation in Neonates and Infants.

Authors:  C Emoto; T Fukuda; T N Johnson; D M Adams; A A Vinks
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-02-04

Review 5.  A Metabolomics Approach to Pharmacotherapy Personalization.

Authors:  Elena E Balashova; Dmitry L Maslov; Petr G Lokhov
Journal:  J Pers Med       Date:  2018-09-05

6.  Effective low-dose sirolimus regimen for kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon in young infants.

Authors:  Veroniek E M Harbers; Nathalie van der Salm; Sjoert A H Pegge; Carine J M van der Vleuten; Bas H Verhoeven; Sabine L A G Vrancken; Leo J Schultze Kool; Joris Fuijkschot; D Maroeska M W M Te Loo
Journal:  Br J Clin Pharmacol       Date:  2022-01-18       Impact factor: 3.716

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.